期刊文献+

铁死亡调节剂及其在脑卒中中的作用研究进展 被引量:5

Research progress on ferroptosis regulators and their role in stroke
下载PDF
导出
摘要 脑卒中是由于脑部供血不足、脑血管血压升高或脑血管硬化引起局部脑组织发生不可逆损伤的脑部血管疾病,并伴随脑神经元的大量死亡。目前发现凋亡、坏死等多种死亡形式共同导致神经元损伤,而阻断凋亡或坏死却无法完全抑制神经元受损,因此积极寻找新的死亡方式将有助于脑卒中的防治。铁死亡是一种以铁依赖性脂质过氧化为主要特征的细胞死亡方式,在多种疾病中发挥关键作用。研究证实脑卒中发病过程中神经元细胞发生铁死亡,抑制铁死亡对脑卒中具有保护作用。本文将论述谷胱甘肽代谢、游离Fe^(2+)及脂质过氧化在铁死亡中的作用,以及针对三者所发现的铁死亡调节剂,并综述了神经元铁死亡与脑卒中发生机制的相关性以及铁死亡阻断剂对脑卒中的潜在治疗作用。 Stroke is a brain injury caused by sudden rupture or blockage of blood vessels in the brain,with different types and varying degrees death in cellular level.And there is currently no effective treatment for it.Ferroptosis is a new type of cell death discovered in recent years that is related to factors such as lipid peroxides,reactive oxygen species(ROS),and Fe^(2+).Early studies reported that iron accumulation and oxidative damage would occur during the process of stroke.And using iron modifier and free radical scavenger can partially inhibit stroke.Recent studies found that ferroptosis occur in the onset of stroke,but the relationship between the mechanism of ferroptosis and the etiology of stroke is rarely reported.This article reviews the mechanism of ferroptosis(including the disorder of x_(c)^(-) system,the accumulation of free Fe^(2+) and the formation of lipid peroxide),and reviews the etiology of stroke and the application of ferroptosis regulators in stroke.
作者 张海林 陈勇 巴永峰 鲁超 胡伟 周仁鹏 ZHANG Hailin;CHEN Yong;BA Yongfeng;LU Chao;HU Wei;ZHOU Renpeng(Department of Clinical Pharmacology,The Second Hospital of Anhui Medical University,Hefei 230601,Anhui,China;School of Pharmacy,Anhui Medical University,Hefei 230032,Anhui,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2021年第11期1320-1327,共8页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(819021826) 安徽省自然科学基金(1908085QH317) 安徽医科大学校基金(2018xkj044)。
关键词 铁死亡 游离Fe^(2+) 脂质过氧化 调节剂 脑卒中 ferroptosis free Fe 2+ lipid peroxide regulator stroke
  • 相关文献

参考文献3

二级参考文献19

  • 1孙运娟.尼莫地平对脑缺血的实验研究及其临床应用进展[J].国外医学(脑血管疾病分册),1996,4(2):97-101. 被引量:34
  • 2Dubal DB, Shughrue PJ, Wilson ME, et al. Estradiol modulates bcl-2 in cerebral tschemia, a potential role for estrogen receptors. J Neurosci, 1999; 19:6385-93
  • 3Tonder N. Neural fransplantation to the normal and Lesioned brain: an experimental study of the rat hippocampus.Acta Neurol Scand, 1995;160(suppl):1-30
  • 4Aoki H, Onoclera H, Yac T, et al. Neural grafting to ischemic CAL Lesions in the rat hippocampus: an antoradiographi study. Neuroscience, 1993;56: 345-54
  • 5Tanne D, Mansbach HH, Verro P. Intravenous rtpA therapy for stroke in clinical practice: a multicenter evaluation of out come. Stroke, 1998;29:288
  • 6Furlan A, Higashida R, wechsler L, et al. Intra-arterial prourokinase for acute inchemic stroke. The PROACT Ⅱ study: arandonized controlled trial prolyse in Acute cerebral Thromboembilism. JAMA, 1999;1:282:2003
  • 7Bednar MM, Gross CE. Antiplatelet therapy in acute cerebral ischemia. Stroke, 1999;30:887-93
  • 8Lyden PD, Loozo L. Combination therapy protects ischemia brain in rat. Stroke, 1998;29:918-23
  • 9Yamaguchi T, Sano K, Takakura K, et al. Ebselen in acute ischemic stroke:a place bocoufrolled, double-blind clinical trial. Stroke, 1998;29: 12-7
  • 10Horn J, Limburg M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev, 2000;2:CD001928

共引文献33

同被引文献60

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部